A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Ublituximab | Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: LFB-R603; TG-1101; TGTX-1101. CAS No. 1174014-05-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99538. |  |
| UBP1112 | UBP1112 is a selective group III mGlu receptor antagonist (apparent Kd=5.1 and 488 μM for group III and group II mGlu receptors respectively; IC50 > 1 mM for group I, NMDA, AMPA and kainate receptors). Synonyms: UBP1112; UBP 1112; UBP-1112; α-Methyl-3-methyl-4-phosphonophenylglycine; 2-amino-2-(3-methyl-4-phosphonophenyl)propanoic acid. Grades: ≥99% by HPLC. CAS No. 339526-74-8. Molecular formula: C10H14NO5P. Mole weight: 259.2. |  |
| UBP1112 | UBP1112. Group: Biochemicals. Grades: Purified. CAS No. 339526-74-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. |  Worldwide |
| UBP 282 | UBP 282. Group: Biochemicals. Grades: Purified. CAS No. 544697-47-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| UBP 282 | UBP 282 is an AMPA and kainate receptor antagonist. UBP 282 inhibits AMPA receptor-, but not kainate receptor-mediated currents on spinal neonatal motoneurons yet antagonizes kainate-induced responses on dorsal root C-fibres. Synonyms: UBP-282, UBP 282, UBP282; (αS)-α-Amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid; VBP. Grades: ≥98% by HPLC. CAS No. 544697-47-4. Molecular formula: C15H15N3O6. Mole weight: 333.3. | |
| UBP 296 | UBP 296 is a selective GLUK5 (GluR5)-subunit containing kainate receptor antagonist (apparent KD = 1.09 μM) that displays ~ 90-fold selectivity over AMPA receptors and recombinant human GluR6- and KA2-containing kainate receptors. It has no activity at NMDA or group I mGlu receptors. UBP 296 was shown to selectively block kainate receptor-mediated LTP induction in rat hippocampal mossy fibers. Synonyms: UBP 296; UBP296; UBP-296; (RS)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxybenzyl)pyrimidine-2,4-dione; 2-[[3-(2-amino-2-carboxyethyl)-2,6-dioxopyrimidin-1-yl]methyl]benzoic acid. Grades: ≥98% by HPLC. CAS No. 745055-86-1. Molecular formula: C15H15N3O6. Mole weight: 333.3. | |
| UBP 296 | UBP 296. Group: Biochemicals. Grades: Purified. CAS No. 745055-86-1. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| UBP 301 | UBP 301. Group: Biochemicals. Grades: Purified. CAS No. 569371-10-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| UBP 301 | UBP 301 is a potent kainate receptor antagonist (apparent Kd = 5.94 μM), displaying ~ 30-fold selectivity over AMPA receptors. Synonyms: UBP 301; UBP301; UBP-301; (αS)-α-Amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-5-iodo-2,4-dioxo-1(2H)-pyrimidinepropanoic acid; 4-[[3-[(2S)-2-amino-2-carboxyethyl]-5-iodo-2,6-dioxopyrimidin-1-yl]methyl]benzoic acid. Grades: ≥98% by HPLC. CAS No. 569371-10-4. Molecular formula: C15H14IN3O6. Mole weight: 459.2. | |
| UBP302 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| UBP 302 | UBP 302 is a potent and selective GLUK5 (GluR5)-subunit containing kainate receptor antagonist (apparent KD = 402 nM) that displays ~ 260-fold selectivity over AMPA receptors, ~ 90-fold selectivity over recombinant human GLUK6- and GLUK2-containing kainate receptors. It has no activity at NMDA or group I mGlu receptors. UBP 302 was shown to block kainate receptor-mediated LTP induction in rat hippocampal mossy fibers. Synonyms: UBP302, UBP-302, UBP 302; (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxybenzyl)pyrimidine-2,4-dione; 2-[[3-[(2S)-2-amino-2-carboxyethyl]-2,6-dioxopyrimidin-1-yl]methyl]benzoic acid. Grades: ≥98% by HPLC. CAS No. 745055-91-8. Molecular formula: C15H15N3O6. Mole weight: 333.3. | |
| UBP 302 | UBP 302. Group: Biochemicals. Grades: Purified. CAS No. 745055-91-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| UBP 310 | UBP 310. Group: Biochemicals. Grades: Purified. CAS No. 902464-46-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| UBP 310 | UBP 310 is a GLUK5 kainate receptor antagonist (IC50 = 130 nM), displaying 12,700-fold selectivity for GLUK5 over GLUK6. It has no activity at mGlu group I or NMDA receptors at concentrations of up to 10 μM. UBP 310 also blocks recombinant homomeric GLUK7 receptors. Synonyms: UBP310, UBP 310, UBP-310; (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-thiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione; 3-[[3-(2-amino-2-carboxyethyl)-5-methylidene-2,6-dioxopyrimidin-3-ium-1-yl]methyl]thiophene-2-carboxylic acid. Grades: ≥98% by HPLC. CAS No. 902464-46-4. Molecular formula: C14H15N3O6S. Mole weight: 353.35. | |
| UBP310 (GluK1/GluK3 Antagonist, UBP310, (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-thiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione, UBP-310, UBP 310) | A potent antagonist highly selective for GluK1 (Kb = 10nM), GluK3 (IC50 = 23nM), and GluK1/K5 (Kb = 8nM) subtype kainate receptors. Does not interact with GluK2 and GluK2/K5 receptors. Low affinity to AMPA receptors (Kd = 83uM). Does not interact with mGluR1 ornMDA receptors at concentration less than 10uM. Often used in studying neuronal excitability and synaptic plasticity. Group: Biochemicals. Grades: Highly Purified. CAS No. 902464-46-4. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| UBP608 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| UBP714 | ?95% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Ubrogepant | Ubrogepant (MK-1602) is an orally active and selective antagonist of calcitonin gene-related peptide receptor ( CGRP ). Ubrogepant has high affinity for CGRP receptors in human and rhesus monkeys, and can effectively block the cAMP response stimulated by α-CGRP. Ubrogepant can be used in the study of acute migraine [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: MK-1602. CAS No. 1374248-77-7. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12366. | |
| Ubrogepant | Ubrogepant is and selective oral calcitonin gene-related peptide (CGRP) receptor antagonist originated by Merck & Co. In Sep 2016, Allergan initiated a phase III extension trial for Migraine in USA. Uses: Migraine. Synonyms: MK-1602; MK 1602; MK1602; Ubrogepant; (3'S)-1',2',5,7-Tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2'-oxo-spiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide. Grades: 98%. CAS No. 1374248-77-7. Molecular formula: C29H26F3N5O3. Mole weight: 549.55. | |
| UBX1325 | UBX1325 is an Bcl-xL inhibitor that promotes apoptosis in senescent cells. UBX1325 is a potent anti-aging agent that can be used in studies of age-related eye diseases such as diabetic macular oedema (DME), age-related macular degeneration (AMD) and diabetic retinopathy (DR)[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2271269-01-1. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-150069. | |
| UBX domain-containing protein 11 (447-460) | UBX domain-containing protein 11 (447-460) is a peptide derived from UBX domain-containing protein 11. UBX domain-containing protein 11 is involved in the reorganization of actin cytoskeleton mediated by RND1, RND2 AND RND3. It promotes RHOA activation mediated by GNA12 and GNA13. Synonyms: Colorectal tumor-associated antigen COA-1 (447-460); UBX domain-containing protein 5 (447-460). | |
| UC 112 | UC 112. Group: Biochemicals. Grades: Purified. CAS No. 383392-66-3. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| UC 112 | UC-112 is an IAP inhibitor (IC50 values from 0.7 - 3.4 μM). UC-112 also potently inhibits the growth of P-glycoprotein. Uses: Iap inhibitor. Synonyms: UC-112; UC 112; UC112; 5-((benzyloxy)methyl)-7-(pyrrolidin-1-ylmethyl)quinolin-8-ol; (Z,6R)-2-methyl-6-[(5R,9R,10R,13R,14R,17R)-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-2-enoic acid. Grades: ≥98%. CAS No. 383392-66-3. Molecular formula: C22H24N2O2. Mole weight: 348.44. | |
| UC2288 | UC2288 is a potent and orally active p21 attenuator (relatively selective activity for p21), which is synthesized based Sorafenib (HY-10201). UC2288 potently inhibits cancer cell growth by inducing apoptosis. UC2288 has no inhibition of VEGFR2 and Raf kinases even at 10 ?M[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1394011-91-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg. Product ID: HY-112780. | |
| UCA 1064-A | UCA 1064-A is an antitumor antibiotic isolated from Wallemia sebi, which inhibits HeLa S3 cells with IC50 of 12.7 μmol/L, suppresses saccharomyces cerevisiae and gram-positive bacteria with MIC of 0.05 and 40 μg/mL, respectively. Molecular formula: C28H45NO. Mole weight: 411.66. | |
| UCA 1064-B | UCA 1064-B is an antitumor antibiotic isolated from Wallemia sebi, which inhibits HeLa S3 cells with IC50 of 14.8 μmol/L, suppresses saccharomyces cerevisiae and gram-positive bacteria with MIC of 0.39 and 40 μg/mL, respectively. Molecular formula: C28H47NO. Mole weight: 413.68. | |
| Ucar Solution Vinyl Resin 9003-22-9 | Ucar Solution Vinyl Resin - Surface Coatings. SUPPLIERS TO BUSINESS CUSTOMERS ONLY. |  North America & APAC |
| UCB 35625 | UCB 35625 is a potent CCR1 and CCR3 antagonist. Synonyms: UCB35625, UCB 35625, UCB-35625; 1,4-TRANS-1-(1-CYCLOOCTEN-1-YLMETHYL)-4-[[(2,7-DICHLORO-9H-XANTHEN-9-YL)CARBONYL]AMINO]-1-ETHYLPIPERIDINIUM IODIDE. CAS No. 301648-08-8. Molecular formula: C30H37Cl2IN2O2. Mole weight: 655.44. | |
| UCB 35625 | UCB 35625. Group: Biochemicals. Grades: Purified. Pack Sizes: 1mg, 10mg. US Biological Life Sciences. | Worldwide |
| UCB-6876 | UCB-6876 is a TNF? inhibitor. UCB-6876 can specifically bind to the asymmetric crystalline form of the TNF-? trimer, with a KD of 22 ?M[1][2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 637324-45-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-156454. | |
| UCB-9260 | UCB-9260, an orally active compound, inhibits TNF signaling by stabilising an asymmetric form of the trimer. UCB-9260 is selective for TNF over other superfamily members, and binds TNF with a similar Kd of 13?nM[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1515888-53-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-133122. | |
| UCD38B hydrochloride | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| UCE1022 | UCE1022 is a cytotoxin with topoisomerase I mediated DNA cleavage activity. Synonyms: UCE-1022; UCE 1022. CAS No. 158243-10-8. Molecular formula: C18H10O10S. Mole weight: 418.3. | |
| UCE 6 | UCE 6 is an antitumor metabolite with topoisomerase I mediated DNA cleavage activity. Synonyms: UCE-6; UCE6. CAS No. 150829-94-0. Molecular formula: C24H20O8. Mole weight: 436.4. | |
| Ucenprubart | Ucenprubart is an anti- CD200R1 human IgG4κ monoclonal antibody [1]. Recommend Isotype Controls: Human IgG4 kappa, Isotype Control (HY-P99003). Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 2414559-57-0. Pack Sizes: 1 mg. Product ID: HY-P990770. | |
| Ucf-101 | Ucf-101 is a selective and competitive inhibitor of pro-apoptotic protease Omi/HtrA2 , with an IC 50 of 9.5 μM for His-Omi. Ucf-101 exhibits very little activity against various other serine proteases (IC 50 >200 μM). Ucf-101 has a natural red fluorescence at 543 nm that is used to monitor its ability to enter mammalian cells. Ucf-101 has a significant cardioprotective effect against MI/R injury and also has certain neuroprotective effect [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 313649-08-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-125959. | |
| UCF 101 | UCF 101 is an Omi/HtrA2 protease inhibitor with IC50 value of 9.5 μM. Omi/HtrA2 is a mitochondria serine protease released in response to apoptotic stimuli. UCF 101 is naturally fluorescent enabling the visualization of its entry into cells. Synonyms: RT-014861; 5-({5-[2-(Dihydroxyamino)phenyl]furan-2-yl}methylidene)-1,3-diphenyl-2-sulfanylidenedihydropyrimidine-4,6(1H,5H)-dione. Grades: ≥98%. CAS No. 313649-08-0. Molecular formula: C27H17N3O5S. Mole weight: 495.5. | |
| UCF-101 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| UCF116-A | UCF116-A is a FTase inhibitor produced by Steptomyces sp. Molecular formula: C37H48N2O8. Mole weight: 648.78. | |
| UCF116-B | UCF116-B is a FTase inhibitor produced by Steptomyces sp. Molecular formula: C36H48N2O8. Mole weight: 636.77. | |
| UCF116-C | UCF116-C is a metabolite produced by Steptomyces sp. It is inactive for Ftase. Molecular formula: C34H46N2O8. Mole weight: 610.74. | |
| UCF76-A | UCF76-A is a FTase inhibitor produced by Steptomyces sp. Molecular formula: C19H20O7. Mole weight: 360.36. | |
| UCF76-B | UCF76-B is a FTase inhibitor produced by Steptomyces sp. Molecular formula: C18H16O7. Mole weight: 344.31. | |
| UCF76-C | UCF76-C is a FTase inhibitor produced by Steptomyces sp. Molecular formula: C18H16O6. Mole weight: 328.32. | |
| UCH9 | UCH9 is an antitumor antibiotic produced Streptomyces. II. It exhibits bacteriophage and gram-positive bacteria activity. Synonyms: UCH-9; UCH 9. Molecular formula: C55H82O24. Mole weight: 1127.2. | |
| UCHL1, His tagged human | recombinant, expressed in E. coli, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| UCH-L1 Inhibitor - CAS 668467-91-2 | The UCH-L1 Inhibitor, also referenced under CAS 668467-91-2, controls the biological activity of UCH-L1. This small molecule/inhibitor is primarily used for Protease Inhibitors applications. Group: Fluorescence/luminescence spectroscopy. | |
| UCHL3 active human | recombinant, expressed in baculovirus infected Sf9 cells, ?90% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| UCL 1684 | UCL 1684 is a potent and nonpeptidic blocker of the apamin-sensitive Ca2+-activated K+ channel (KCa2.1) (IC50 = 3 nM in rat sympathetic neurons). UCL 1684 was shown to block hKCa2.1 and rKCa2.2 channels expressed in HEK 293 cells (IC50 = 762 and 364 pM, respectively). Synonyms: UCL-1684 Dibromide; UCL 1684 Dibromide; UCL1684 Dibromide; UCL-1684 Br; UCL 1684 Br; UCL1684 Br; 6,12,19,20,25,26-Hexahydro-5,27:13,18:21,24-trietheno-11,7-metheno-7H-dibenzo [b,n] [1,5,12,16]tetraazacyclotricosine-5,13-diium dibromide. Grades: ≥97% by HPLC. CAS No. 199934-16-2. Molecular formula: C34H30Br2N4. Mole weight: 654.44. | |
| UCL 2077 | UCL 2077 is a slow afterhyperpolarization (sAHP) channel blocker that reduces sAHP in hippocampal slice preparations. UCL 2077 exhibits no effect on Ca2+ currents or the time course of sAHP/sIAHP. It also inhibits KCNQ1 and KCNQ2. Synonyms: UCL2077, UCL 2077, UCL-2077; N-Trityl-3-pyridinemethanamine; (3-Triphenylmethylaminomethyl)pyridine. Grades: ≥99% by HPLC. CAS No. 918311-87-2. Molecular formula: C25H22N2. Mole weight: 350.46. | |
| UCL 2077 | UCL 2077. Group: Biochemicals. Grades: Purified. CAS No. 918311-87-2. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| UCL 2077 | ?98% (HPLC), solid. Group: Fluorescence/luminescence spectroscopy. | |
| UCLA GP130 2 | UCLA GP130 2 is a brain-penetrant gp130 agonist, protecting against NMDA-induced toxicity in primary hippocampal neurons in vitro, and increasing STAT3 phosphorylation in SH-SY5Y cells. Synonyms: N-(4-Fluorophenyl)-4-phenyl-2-thiazolamine. Grades: ≥98% by HPLC. CAS No. 339303-87-6. Molecular formula: C15H11FN2S. Mole weight: 270.32. | |
| UCL-TRO-1938 | UCL-TRO-1938 is a potent small molecule allosteric activator of PI3K? with an EC50 value of approximately 60 ?M. UCL-TRO-1938 can induce cell proliferation and has cardioprotective effects from ischaemia reperfusion injury and enhances nerve regeneration following nerve crush[1][2][3][4][5]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2919575-27-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-154848. | |
| UCM53 | UCM53 is an inhibitor of bacterial cell division that binds to the GTP site of the cell division protein FtsZ. It inhibits the growth of clinical isolates of antibiotic-resistant Staphylococcus aureus and Enterococcus faecalis. Synonyms: [4-(3-Chloro-4-hydroxybenzoyl)oxynaphthalen-2-yl] 3,4-dihydroxybenzoate. Grades: ≥98%. CAS No. 1449468-52-3. Molecular formula: C24H15ClO7. Mole weight: 450.8. | |
| UCM 707 | UCM 707. Group: Biochemicals. Grades: Purified. CAS No. 390824-20-1. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| UCM 707 | UCM 707 is a potent endocannabinoid transport inhibitor (IC50 = 0.8 and 30 μM for inhibition of the anandamide transporter and FAAH, respectively). UCM 707 potentiates hypokinetic and antinociceptive effects of anandamide in vivo. Synonyms: UCM 707; UCM707; UCM-707; (5Z,8Z,11Z,14Z)-N-(3-Furanylmethyl)-5,8,11,14-eicosatetraenamide; N-(furan-3-ylmethyl)icosa-5,8,11,14-tetraenamide. CAS No. 390824-20-1. Molecular formula: C25H37NO2. Mole weight: 383.57. | |
| UCM710 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| UCN-01 | KRX-0601, also known as UCN-01, is a synthetic derivative of staurosporine with antineoplastic activity. It inhibits many phosphokinases, including the serine/threonine kinase AKT, calcium-dependent protein kinase C, and cyclin-dependent kinases. This agent arrests tumor cells in the G1/S of the cell cycle and prevents nucleotide excision repair by inhibiting the G2 checkpoint kinase chk1, resulting apoptosis. Uses: Antineoplastic agents. Synonyms: Antibiotic UCN 01; UCN01; Staurosporine; 7-hydroxystaurosporine; KW-2401; KW 2401; KW2401; (3R,9S,10R,11R,13R)-2,3,10,11,12,13-Hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; (+)-UCN-01; KRX 0601; NSC 638850. Grades: >99% by HPLC. CAS No. 112953-11-4. Molecular formula: C28H26N4O4. Mole weight: 482.53. | |
| UCN-02 | UCN-02 is an indolocarbazole isolated from a high staurosporine-producing Streptomyces culture with antineoplastic activity. It inhibits many phosphokinases, including the serine/threonine kinase AKT, calcium-dependent protein kinase C, and cyclin-dependent kinases. Synonyms: Antibiotic UCN 02; UCN02; GNF-Pf-3072; 7-hydroxy-staurosporine; 7-epi-Hydroxystaurosporine; (3S,9S,10R,11R,13R)-2,3,10,11,12,13-Hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; [3S-(3α, 9α, 10β, 11β, 13α)]-2, 3, 10, 11, 12, 13-Hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-9, 13-epoxy-1H, 9H-diindolo[1, 2, 3-gh:3', 2', 1'-lm]pyrrolo[3, 4-j][1, 7]benzodiazonin-1-one. Grades: >95% by HPLC. CAS No. 121569-61-7. Molecular formula: C28H26N4O4. Mole weight: 482.53. | |
| Ucph 101 | Ucph 101. Uses: Designed for use in research and industrial production. Additional or Alternative Names: UCPH 101. Product Category: Heterocyclic Organic Compound. CAS No. 1118460-77-7. Molecular formula: C27H22N2O3. Mole weight: C27H22N2O3. Purity: >98 %. IUPACName: 2-amino-4-(4-methoxyphenyl)-7-naphthalen-1-yl-5-oxo-4,6,7,8-tetrahydrochromene-3-carbonitrile. Canonical SMILES: COC1=CC=C(C=C1)C2C(=C(OC3=C2C(=O)CC(C3)C4=CC=CC5=CC=CC=C54)N)C#N. Product ID: ACM1118460777. Alfa Chemistry ISO 9001:2015 Certified. Categories: UCPH-101. |  |
| UCPH 101 | UCPH 101 is a selective non-substrate inhibitor of EAAT1 (IC50 = 660, >300000 and >300000 nM for EAAT1, EAAT2 and EAAT3, respectively). UCPH 101 selectively inhibits anion currents in tsA201 cells expressing human EAAT1 (Kd = 0.34 μM) over rat EAAT4 and mouse EAAT5 at concentrations up to 10 μM. Synonyms: UCPH-101, UCPH 101, UCPH101; 2-Amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-4H-chromene-3-carbonitrile. Grades: ≥98% by HPLC. CAS No. 1118460-77-7. Molecular formula: C27H22N2O3. Mole weight: 422.48. | |
| UCPH-101 | UCPH-101 is an excitatory amino acid transporter subtype 1 (EAAT1) inhibitor with an IC50 of 0.66 ?M. Uses: Scientific research. Group: Signaling pathways. CAS No. 1118460-77-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10914. | |
| UCPH-102 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| UCS1025 A | UCS1025 A is an antitumor antibiotic isolated from Acremonium sp. KY4917. It exhibits activity against gram-positive bacteria including Staphylococcus and Enterococcus, and proteusbacillus vulgaris. It also inhibits cell proliferation. Synonyms: UCS 1025A. Molecular formula: C22H29NO5. Mole weight: 387.47. | |
| UCS1025 B | UCS1025 B is an antitumor antibiotic isolated from Acremonium sp. KY4917. It exhibits activity against gram-positive bacteria including Staphylococcus and Enterococcus, and proteusbacillus vulgaris. It also inhibits cell proliferation. The activity of B is much weaker than that of A. Synonyms: UCS 1025B. Molecular formula: C22H29NO6. Mole weight: 403.47. | |
| UCSF924NC | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| UCT 1072M1 | UCT 1072M1 is a topoisomerase II poison isolated from Aspergillus sp. KY4919, which is toxic to HeLa S3 and Lu-65 cells. Synonyms: UCT1072M1; UCT-1072M1. Molecular formula: C18H12O8. Mole weight: 356.28. | |
| UCT 1072M2 | UCT 1072M2 is a topoisomerase II poison isolated from Aspergillus sp. KY4919, which is toxic to HeLa S3 and Lu-65 cells. Synonyms: UCT1072M2; UCT-1072M2. Molecular formula: C20H16O7. Mole weight: 368.34. | |
| UCT 1072M3 | UCT 1072M3 is a topoisomerase II poison isolated from Aspergillus sp. KY4919, which is toxic to HeLa S3 and Lu-65 cells. UCT 1072M3 is a diastereomer of UCT 1072M2. Synonyms: UCT1072M3; UCT-1072M3. Molecular formula: C20H16O7. Mole weight: 368.34. | |
Our database is helping our users find suppliers everyday.
